+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Escherichia coli recombinant sperm immobilizing factor RecX as a potential vaginal contraceptive



Escherichia coli recombinant sperm immobilizing factor RecX as a potential vaginal contraceptive



Reproductive Biology and Endocrinology 16(1): 88



To control the overpopulation and unintended pregnancies, vaginal contraceptives have gained recent surge of interest because of its topical application with possible avoidance of systemic effects. However non-specific cytotoxicity associated with detergent-based synthetic vaginal contraceptive agents limits their use and generates considerable interest in the development of vaginal contraceptives of biological origin for controlling reproduction and ultimately growing population. In this study, we have cloned, over-expressed an Escherichia coli gene encoding a sperm immobilizing factor (SIF) that inhibits sperm motility for the development of vaginal contraceptive from a biological source i.e. E. coli. The contraceptive efficacy of the Escherichia coli recombinant sperm immobilizing factor (r-SIF) was also determined. Genomic DNA library of an E. coli strain isolated from semen sample of an infertile male was constructed for the identification and cloning of E. coli SIF coding gene. This gene was sub-cloned in pBADmycHisB for over-expression and the r-SIF was purified using Ni-NTA affinity chromatography. Effect of r-SIF on mouse sperm motility, viability and on morphology was evaluated. Binding of r-SIF to mouse sperm was demonstrated by fluorescent labeling. Contraceptive efficacy of r-SIF was checked in murine model. Genomic library resulted in five hundred transformants; five clones were found positive for sperm immobilizing activity. The protein product of the insert DNA sequence in one of the transformants showed maximum sperm immobilizing activity. Sequence analysis of ORFs in the insert revealed homology to recX on both nucleotide and protein level. 40 μg of the purified r-SIF showed immediate spermicidal activity in vitro for mouse sperm. Scanning electron micrograph of the r-SIF treated sperm showed intense morphological damage to sperm. FITC labeled r-SIF showed highest fluorescence at the head region of the sperm. 5 μg of purified r-SIF exhibited a complete contraceptive effect in mouse model. r-SIF could be seen as potential target to be developed as potent and safe vaginal contraceptive in future.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065776784

Download citation: RISBibTeXText

PMID: 30213271

DOI: 10.1186/s12958-018-0407-1


Related references

Glutathione and caffeine antagonize the sperm-immobilizing effect of a vaginal contraceptive. Human Toxicology 3(4): 271-277, 1984

Deinococcus radiodurans RecX and Escherichia coli RecX Proteins Are Able to Replace Each Other in vivo and in vitro. Genetika 52(3): 293-299, 2016

Exploitation of sperm-Escherichia coli interaction at the receptor-ligand level for the development of anti-receptor antibodies as the vaginal contraceptive. Andrology 3(2): 385-394, 2015

Effect of antibodies to sperm-specific recombinant contraceptive vaccinogen (rCV) on murine fertilization: search for an animal model to examine its contraceptive potential. Molecular Reproduction and Development 60(3): 425-432, 2001

Vaginal colonization of Escherichia coli and its relation to contraceptive methods. Contraception 27(5): 497-504, 1983

Immunogenicity and contraceptive potential of recombinant human sperm associated antigen (SPAG9). Journal of Reproductive Immunology 67(1-2): 69-76, 2005

DinI and RecX modulate RecA-DNA structures in Escherichia coli K-12. Molecular Microbiology 63(1): 103-115, 2007

Determination of immunoglobulin classes and subclasses of sperm immobilizing antibodies in infertile women and the inhibitory effect of IgG4 subclass on the sperm immobilizing antibody activity. Journal of Reproductive Immunology 24(3): 223-233, 1993

Is the sperm bacterial ratio a determining factor in impairment of sperm motility: an in-vitro study in man with Escherichia coli. International Journal of Andrology 14(4): 264-270, 1991

P-fimbriae of Escherichia coli as carriers for gonadotropin releasing hormone: Development of a recombinant contraceptive vaccine. Vaccine 13(8): 753-758, 1995

Immunogenicity and contraceptive efficacy of Escherichia coli-expressed recombinant porcine zona pellucida proteins. American Journal of Reproductive Immunology 70(2): 139-152, 2013

Adherence of Escherichia coli to sperm: A mannose mediated phenomenon leading to agglutination of sperm and Escherichia coli. Fertility and Sterility 60(1): 154-158, 1993

Effect of sperm immobilizing antibodies on sperm penetration in the cervical mucus 1. sperm penetration test and micro sperm immobilization test in the cervical mucus from sterile women with sperm immobilizing antibody in the sera. Japanese Journal of Fertility and Sterility 25(1): 1-7, 1980

Vaginal Escherichia coli share common virulence factor profiles, serotypes and phylogeny with other extraintestinal E. coli. Microbiology 148(Pt 9): 2745-2752, 2002

Escherichia coli RecX inhibits RecA recombinase and coprotease activities in vitro and in vivo. Journal of Biological Chemistry 278(4): 2278-2285, 2003